Atrial Fibrillation Trial, Recruiting (NCT07301190)

Atrial Fibrillation Trial, Recruiting NCT07301190 Sponsor: The Third People's Hospital of Chengdu Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT07301190 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 75 years old (either gender)
You have been diagnosed with persistent atrial fibrillation (an irregular heart rhythm lasting more than 7 days) that is causing symptoms
Your medical records show evidence of this ongoing irregular heart rhythm, either from a 24-hour heart monitor recording or from two separate heart trace (ECG) tests taken more than 7 days apart, both done within the past year
At least one medication used to control heart rhythm has either not worked well enough for you, or you were unable to tolerate it
You are willing to take part in the trial, attend all required follow-up visits, and sign a consent form

Who may not be able to join:

Your atrial fibrillation comes and goes in short episodes (called paroxysmal AF) rather than being persistent
Your atrial fibrillation is caused by an imbalance of body salts, a thyroid condition, or another reversible or non-heart-related cause
You have previously had a procedure (ablation) to treat a fast heart rhythm and are now seeking repeat treatment
You have a history of dangerous fast heart rhythms originating in the lower chambers of your heart
The upper left chamber of your heart is larger than a certain size (confirm with trial site)
You have significant narrowing or a stent in the veins connecting your lungs to your heart
You have previously had a heart procedure or surgery involving the upper chambers of your heart, including any procedure to close off a small pouch on the heart called the left atrial appendage
You have a permanent pacemaker, a defibrillator device, or a heart monitor implanted in your body
You are unable to take blood-thinning medications, or you have a history of abnormal bleeding or clotting problems
You have a severe lung condition, including severe high blood pressure in the lung arteries or any serious lung disease causing significant breathing difficulties
You have an artificial heart valve, severely reduced heart pumping function (less than 40%), a hole between the chambers of your heart that has been repaired, a tumour in the heart, or a device implanted to close off the left atrial appendage
Within the past 3 months, you have had a heart attack, unstable chest pain, a heart stenting procedure, heart surgery, a hospital stay for heart failure, or inflammation around the heart
Within the past 3 months, you have had a stroke, a mini-stroke (TIA), or a confirmed blood clot event
You have or have had a cancer diagnosis, or your life expectancy is less than 12 months
You have a mental health condition that would prevent you from participating independently
You are currently pregnant, breastfeeding, or planning to become pregnant
You have an active or serious infection, or significantly reduced liver or kidney function
You are currently taking part in another interventional clinical trial, or the trial doctor considers you unsuitable for another reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8619980510703

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07301190

Sponsor: The Third People's Hospital of Chengdu

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: 8619980510703

More information: https://clinicaltrials.gov/study/NCT07301190

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 75 years old (either gender)
You have been diagnosed with persistent atrial fibrillation (an irregular heart rhythm lasting more than 7 days) that is causing symptoms
Your medical records show evidence of this ongoing irregular heart rhythm, either from a 24-hour heart monitor recording or from two separate heart trace (ECG) tests taken more than 7 days apart, both done within the past year
At least one medication used to control heart rhythm has either not worked well enough for you, or you were unable to tolerate it
You are willing to take part in the trial, attend all required follow-up visits, and sign a consent form

Who may not be able to join:

Your atrial fibrillation comes and goes in short episodes (called paroxysmal AF) rather than being persistent
Your atrial fibrillation is caused by an imbalance of body salts, a thyroid condition, or another reversible or non-heart-related cause
You have previously had a procedure (ablation) to treat a fast heart rhythm and are now seeking repeat treatment
You have a history of dangerous fast heart rhythms originating in the lower chambers of your heart
The upper left chamber of your heart is larger than a certain size (confirm with trial site)
You have significant narrowing or a stent in the veins connecting your lungs to your heart
You have previously had a heart procedure or surgery involving the upper chambers of your heart, including any procedure to close off a small pouch on the heart called the left atrial appendage
You have a permanent pacemaker, a defibrillator device, or a heart monitor implanted in your body
You are unable to take blood-thinning medications, or you have a history of abnormal bleeding or clotting problems
You have a severe lung condition, including severe high blood pressure in the lung arteries or any serious lung disease causing significant breathing difficulties
You have an artificial heart valve, severely reduced heart pumping function (less than 40%), a hole between the chambers of your heart that has been repaired, a tumour in the heart, or a device implanted to close off the left atrial appendage
Within the past 3 months, you have had a heart attack, unstable chest pain, a heart stenting procedure, heart surgery, a hospital stay for heart failure, or inflammation around the heart
Within the past 3 months, you have had a stroke, a mini-stroke (TIA), or a confirmed blood clot event
You have or have had a cancer diagnosis, or your life expectancy is less than 12 months
You have a mental health condition that would prevent you from participating independently
You are currently pregnant, breastfeeding, or planning to become pregnant
You have an active or serious infection, or significantly reduced liver or kidney function
You are currently taking part in another interventional clinical trial, or the trial doctor considers you unsuitable for another reason

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Third People's Hospital of Chengdu

Registry

ClinicalTrials.gov

Start date

11 June 2025

Est. completion

31 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The primary safety endpoint; The primary efficacy endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov